William F. Bell Jr. - Jun 6, 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Director
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol
PTCT
Transactions as of
Jun 6, 2023
Transactions value $
$0
Form type
4
Date filed
6/7/2023, 04:07 PM
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Award $0 +4K $0.00 4K Jun 6, 2023 Direct F1
transaction PTCT Common Stock Award $0 +2.33K +58.33% $0.00 6.33K Jun 6, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right to Buy) Award $0 +10K $0.00 10K Jun 6, 2023 Common Stock 10K $45.02 Direct F3
transaction PTCT Stock Option (Right to Buy) Award $0 +5.83K $0.00 5.83K Jun 6, 2023 Common Stock 5.83K $45.02 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on June 6, 2023 that vest in three equal installments over three years, commencing on June 6, 2024.
F2 Restricted stock units granted on June 6, 2023 that vest on January 5, 2024.
F3 This option was granted on June 6, 2023 and vests over thirty-six approximately equal monthly installments, commencing on July 6, 2023.
F4 This option was granted on June 6, 2023 and vests over seven approximately equal monthly installments, commencing on July 5, 2023.